Related Experiment Video
Updated: Sep 28, 2025
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.4K
The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for
Luis A Querol1, Hans-Peter Hartung2,3,4,5, Richard A Lewis6
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
Summary
The complement system plays a key role in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pathogenesis. Targeting this system offers a promising therapeutic strategy for CIDP patients, especially those unresponsive to current treatments.
Area of Science:
- Neurology
- Immunology
- Pathophysiology
Background:
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a heterogeneous, immune-mediated neuropathy causing significant disability.
- CIDP involves complex immune responses leading to myelin sheath damage in motor and sensory nerves.
Purpose of the Study:
- To provide a comprehensive overview of evidence for the complement system's role in CIDP.
- To establish a rationale for developing complement-targeted therapies for CIDP.
Main Methods:
- Review of preclinical and clinical evidence.
- Analysis of immune mechanisms in CIDP pathogenesis.
- Examination of complement system involvement in demyelination.
Main Results:
- Evidence suggests the complement system promotes macrophage-mediated demyelination in CIDP.
- Complement deposition and activation are observed in CIDP patients' nerve biopsies, serum, and CSF.
Conclusions:
- The complement system is implicated in the pathogenesis of CIDP.
- Targeting the complement system presents a viable therapeutic avenue for CIDP, particularly for refractory cases.
